BioSpace News Archive

myNEO evolves into myNEO Therapeutics to reflect its new strategy to develop off-the-shelf cancer vaccine immunotherapeutics

myNEO, a biotech company focused on exploiting “dark genome” targets to develop novel therapeutic cancer vaccines, announces its new name – myNEO Therapeutics.

October 25, 2023
·
4 min read
Business

Thermo Fisher Scientific Reports Third Quarter 2023 Results

Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the third quarter ended September 30, 2023.

October 25, 2023
·
8 min read
New multi-centre study in Spain shows very strong interim results for Prostatype®

Prostatype Genomics is currently conducting a study of 160 patients together with seven leading Spanish hospitals and the Spanish National Association of Urology.

October 25, 2023
·
2 min read
Business

Verrica Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 9, 2023

Verrica Pharmaceuticals Inc. today announced that it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, November 9, 2023, to provide a corporate update and discuss the Company’s financial results for the third quarter ended September 30, 2023.

October 25, 2023
·
1 min read
Business

Alkermes plc Reports Third Quarter 2023 Financial Results

Alkermes plc (Nasdaq: ALKS) today reported financial results for the third quarter of 2023.

October 25, 2023
·
16 min read
Business

Samsung Biologics reports third quarter 2023 financial results

Samsung Biologics, the world’s leading contract development and manufacturing organization, announced financial results for the third quarter of fiscal year 2023.

October 25, 2023
·
4 min read
EnginZyme Produces Key mRNA Vaccine Ingredient Using Biocatalysis

EnginZyme AB, a deep-tech company whose cell-free biomanufacturing technology uses the power of enzymes to create sustainable products and processes for a variety of industries, announced that it had patented a process to synthesize pseudouridine, a key ingredient in mRNA COVID-19 vaccines.

October 25, 2023
·
5 min read
BioForest

AGC Biologics Signs TCR-T Cell Services Agreement to Support Medigene’s New Cell Therapy Product

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization, announced a new service agreement with Medigene AG.

October 25, 2023
·
3 min read
Business

United Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023

United Therapeutics Corporation (Nasdaq: UTHR ), announced today that it will report its third quarter 2023 financial results before the market opens on Wednesday, November 1, 2023.

October 25, 2023
·
2 min read
Business

Apellis Pharmaceuticals to Host Conference Call on November 1, 2023, to Discuss Third Quarter 2023 Financial Results

Apellis Pharmaceuticals , Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its third quarter 2023 financial results on Wednesday, November 1, 2023, at 8:00 a.m. ET.

October 25, 2023
·
1 min read